NASDAQ:CYRX

Cryoport Stock Forecast, Price & News

$61.64
+0.37 (+0.60 %)
(As of 08/3/2021 12:00 AM ET)
Add
Compare
Today's Range
$59.06
$62.17
50-Day Range
$53.53
$66.75
52-Week Range
$30.64
$84.97
Volume223,149 shs
Average Volume224,505 shs
Market Capitalization$2.82 billion
P/E RatioN/A
Dividend YieldN/A
Beta0.9
30 days | 90 days | 365 days | Advanced Chart
Receive CYRX News and Ratings via Email

Sign-up to receive the latest news and ratings for Cryoport and its competitors with MarketBeat's FREE daily newsletter.


Cryoport logo

About Cryoport

Cryoport, Inc., a life sciences services company, provides temperature-controlled logistics solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers Cryoportal, a cloud-based logistics management platform that supports the management of shipments, which includes order entry, document preparation, customs documentation, courier management, real-time shipment tracking and monitoring, issue resolution, and regulatory compliance requirements; and CryoPort Express Shippers, which is used to ensure that the stability of shipped biologic commodities are maintained throughout the shipping cycle; and Cryoport Express Advanced Therapy Shippers that provides verification processes to biopharma companies. It also provides information dashboards and validation documentation for shipments through data collected by the SmartPak Condition Monitoring System; and vacuum insulated aluminum dewars and cryogenic freezers systems. In addition, the company offers biological specimen cryopreservation storage and maintenance; archiving, monitoring, tracking, receipt, and delivery of samples; transportation of frozen biological specimens to and from customer locations; and management of incoming and outgoing biological specimens, as well as provides logistics support and management; and short-term logistics and engineering consulting services. It serves biopharma/pharma, animal health, and human reproductive medicine markets. The company was founded in 1999 and is headquartered in Brentwood, Tennessee.

Headlines

See More Headlines

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous


MarketRank

Overall MarketRank

2.22 out of 5 stars

Transportation Sector

64th out of 169 stocks

Pharmaceutical Preparations Industry

146th out of 646 stocks

Analyst Opinion: 2.5Community Rank: 4.7Dividend Strength: 0.0Insider Behavior: 3.3Valuation: 0.6 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles











Cryoport (NASDAQ:CYRX) Frequently Asked Questions

Is Cryoport a buy right now?

8 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Cryoport in the last year. There are currently 8 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Cryoport stock.
View analyst ratings for Cryoport
or view top-rated stocks.

What stocks does MarketBeat like better than Cryoport?

Wall Street analysts have given Cryoport a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Cryoport wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

When is Cryoport's next earnings date?

Cryoport is scheduled to release its next quarterly earnings announcement on Thursday, August 5th 2021.
View our earnings forecast for Cryoport
.

How can I listen to Cryoport's earnings call?

Cryoport will be holding an earnings conference call on Thursday, August 5th at 5:00 PM Eastern. Interested parties can register for or listen to the call using this link or dial in at 412-317-6671 with passcode "5085639".

How were Cryoport's earnings last quarter?

Cryoport, Inc. (NASDAQ:CYRX) issued its quarterly earnings results on Tuesday, May, 4th. The consumer goods maker reported ($0.13) EPS for the quarter, beating the Zacks' consensus estimate of ($0.21) by $0.08. The consumer goods maker earned $53.30 million during the quarter, compared to the consensus estimate of $46.78 million. Cryoport had a negative net margin of 26.41% and a positive trailing twelve-month return on equity of 3.17%. The firm's quarterly revenue was up 443.9% on a year-over-year basis. During the same period last year, the firm posted ($0.11) earnings per share.
View Cryoport's earnings history
.

How has Cryoport's stock price been impacted by Coronavirus (COVID-19)?

Cryoport's stock was trading at $16.62 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, CYRX shares have increased by 270.9% and is now trading at $61.64.
View which stocks have been most impacted by COVID-19
.

What price target have analysts set for CYRX?

8 analysts have issued 1 year target prices for Cryoport's shares. Their forecasts range from $44.00 to $84.00. On average, they expect Cryoport's stock price to reach $73.50 in the next year. This suggests a possible upside of 19.2% from the stock's current price.
View analysts' price targets for Cryoport
or view top-rated stocks among Wall Street analysts.

Who are Cryoport's key executives?

Cryoport's management team includes the following people:
  • Mr. Jerrell W. Shelton, Chairman, Pres & CEO (Age 76, Pay $1.39M)
  • Mr. Robert S. Stefanovich, Sr. VP, CFO, Treasurer & Corp. Sec. (Age 56, Pay $715.37k)
  • Dr. Mark W. Sawicki Ph.D., Sr. VP & Chief Scientific Officer
  • Tony Ippolito, VP & Gen. Counsel
  • Mr. Thomas J. Heinzen, VP of Corp. Devel.
  • Mr. Bret Bollinger, Chief Technology Officer of Cryoport Systems (Age 54)
  • Mr. Phil Wilson, Chief Operating Officer of Cryoport Systems
  • Mr. Raymond Takahashi M.D., Exec. Officer
  • Mr. David Petreccia M.D., Exec. Officer

Who are some of Cryoport's key competitors?

What other stocks do shareholders of Cryoport own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Cryoport investors own include Gilead Sciences (GILD), Advanced Micro Devices (AMD), Micron Technology (MU), NVIDIA (NVDA), Taiwan Semiconductor Manufacturing (TSM), Amarin (AMRN), QUALCOMM (QCOM), Enterprise Products Partners (EPD), Pfizer (PFE) and Square (SQ).

What is Cryoport's stock symbol?

Cryoport trades on the NASDAQ under the ticker symbol "CYRX."

Who are Cryoport's major shareholders?

Cryoport's stock is owned by many different institutional and retail investors. Top institutional shareholders include Granite Investment Partners LLC (2.49%), Victory Capital Management Inc. (1.94%), Handelsbanken Fonder AB (1.64%), Redwood Investments LLC (0.66%), New York State Common Retirement Fund (0.28%) and Roubaix Capital LLC (0.15%). Company insiders that own Cryoport stock include Daniel M Hancock, Edward J Zecchini, Freeze Parent LP Blackstone, Jerrell Shelton, Mark W Sawicki, Michael R Egeck, Richard J Berman and Robert Stefanovich.
View institutional ownership trends for Cryoport
.

Which institutional investors are selling Cryoport stock?

CYRX stock was sold by a variety of institutional investors in the last quarter, including Victory Capital Management Inc., Harel Insurance Investments & Financial Services Ltd., Cutler Group LP, New York State Common Retirement Fund, Advisor Group Holdings Inc., Arizona State Retirement System, Rice Hall James & Associates LLC, and Brinker Capital Investments LLC. Company insiders that have sold Cryoport company stock in the last year include Daniel M Hancock, Edward J Zecchini, Freeze Parent LP Blackstone, Mark W Sawicki, Michael R Egeck, Richard J Berman, and Robert Stefanovich.
View insider buying and selling activity for Cryoport
or view top insider-selling stocks.

Which institutional investors are buying Cryoport stock?

CYRX stock was acquired by a variety of institutional investors in the last quarter, including Handelsbanken Fonder AB, Redwood Investments LLC, Roubaix Capital LLC, Granite Investment Partners LLC, Nkcfo LLC, Diversified Portfolios Inc., Alliancebernstein L.P., and Conestoga Capital Advisors LLC.
View insider buying and selling activity for Cryoport
or or view top insider-buying stocks.

How do I buy shares of Cryoport?

Shares of CYRX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Cryoport's stock price today?

One share of CYRX stock can currently be purchased for approximately $61.64.

How much money does Cryoport make?

Cryoport has a market capitalization of $2.82 billion and generates $78.70 million in revenue each year. The consumer goods maker earns $-32,690,000.00 in net income (profit) each year or ($0.84) on an earnings per share basis.

How many employees does Cryoport have?

Cryoport employs 650 workers across the globe.

What is Cryoport's official website?

The official website for Cryoport is www.cryoport.com.

Where are Cryoport's headquarters?

Cryoport is headquartered at 112 Westwood Place Suite 350, Brentwood TN, 37027.

How can I contact Cryoport?

Cryoport's mailing address is 112 Westwood Place Suite 350, Brentwood TN, 37027. The consumer goods maker can be reached via phone at 949-470-2300 or via email at [email protected]


This page was last updated on 8/4/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.